If most of our work happens in the digital domain, why should our assistants only be flesh and blood analogues, asks Satyen K ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

We tried Shark's vast vacuum lineup and explored the effectiveness of features like lift-away pods, dirt detection, and ...

Walmart's week-long sale has plenty of deals—these are worth your moneyBy Consumer ReportsIf you’ve been waiting for a big ...

Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Screen protectors aren't just about shielding your device. Some offer blue light filtering, anti-glare coatings, and privacy features. Our experts tested a variety of iPad screen protectors to ...

“Affordable occasionwear seems to be only available on ultra-fast fashion sites and it's hard to trust that what you see on the screen is what you will get when your package arrives,” Amlani said.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...